CD274 and adult T-cell leukemia/lymphoma: Genomic analysis of ATLL demonstrated PD-L1 amplifications (Kataoka et al. 2018) and phase2 trial of PD-1 inhibitor therapy has been performed in patients with aggressive ATLL (Ishitsuka et al. 2018).